ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

TDOC vs INNV // FORWARD P/E MULTIPLE

Teladoc Health Inc. (NYSE) VS. InnovAge Holding Corp. (NASDAQ) • 15-METRIC TALLY: TDOC 4 — INNV 5
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (TDOC VS. INNV) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC TDOC INNV SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — 18.00% — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -17.00% -10.20% -6.80 INNV /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield 18.00% 2.11% +15.89 TDOC /fcf-yield <GO>
Operating Margin -10.40% -3.50% -6.90 INNV /operating-margins <GO>
Net Profit Margin -7.90% -3.60% -4.30 INNV /net-margins <GO>
Revenue Growth (YoY) -1.50% 11.80% -13.30 INNV /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 0.45 4.47 -4.02 INNV /balance-sheet <GO>
Piotroski F-Score Quality 7/9 6/9 +1.00 TDOC /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 79.0 47.2 +31.80 TDOC /rsi-technicals <GO>
10Y Yield & FRED Macro Beta 1.08 — — TIE /macro-sensitivity <GO>
Forward P/E Multiple ACTIVE 32.0x — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $1.59B $1.26B $325.2M TDOC /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR TDOC REV INNV REV TDOC GROSS % INNV GROSS % TDOC FCF INNV FCF
FY 2025 $2.53B $853.7M — 18.0% $285.5M $26.6M
FY 2024 $2.57B $763.9M — 17.3% $282.9M -$44.8M
FY 2023 $2.60B $688.1M — — $232.9M $20.2M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
TDOC // BETA 1.08
INNV // BETA —